Table 3.
Antiviral Drugs | Mechanisms/Targets | Virus | IC50/EC50 Value | Reference |
---|---|---|---|---|
Chloroquine | ACE2 receptor and proinflammatory cytokines | SARS-CoV-2 | - | [56] |
Hydroxychloroquine | ||||
NPQ | Affecting both entry and post-entry replication of the virus | HCoV-229E, HCoV-OC43, SARS-CoV-2 | IC50 = 2.05 ± 1.44, 5.83 ± 0.74, and 2.01 ± 0.38 μM, respectively | [61] |